Molecule Details
InChIKeyQFJCIRLUMZQUOT-HPLJOQBZSA-N
Compound NameSirolimus
Canonical SMILESCO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)9
Pfam Stratification Cross-Family
Avg pChEMBL9.07
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00877
Drug NameSirolimus
CAS Number53123-88-9
Groups approved investigational
ATC Codes L01EG04 S01XA23 L04AH01
DescriptionSirolimus, also known as rapamycin, is a macrocyclic lactone antibiotic produced by bacteria _Streptomyces hygroscopicus_, which was isolated from the soil of the Vai Atari region of Rapa Nui (Easter Island).[A242412] It was first isolated and identified as an antifungal agent with potent anticandid...

Categories: Agents causing angioedema Anti-Bacterial Agents Anti-Infective Agents Antibiotics, Antineoplastic Antifungal Agents Antineoplastic and Immunomodulating Agents Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Substrates Decreased Immunologic Activity Hyperglycemia-Associated Agents Immunologic Factors Immunosuppressive Agents Immunotherapy Kinase Inhibitor Lactones Macrolides Mammalian target of rapamycin (mTOR) kinase inhibitors Myelosuppressive Agents Narrow Therapeutic Index Drugs OATP1B1/SLCO1B1 Inhibitors Ophthalmologicals P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates P-glycoprotein substrates with a Narrow Therapeutic Index Polyketides Protein Kinase Inhibitors Selective Immunosuppressants Sensory Organs Sirolimus and Prodrugs mTOR Inhibitor Immunosuppressant mTOR Inhibitors
Cross-references: BindingDB: 50064359 ChEBI: 9168 CHEMBL413 ChemSpider: 10482078 Drugs Product Database (DPD): 12064 C07909 D00753 PDB: RAP PharmGKB: PA451365 PubChem:5284616 PubChem:46505675 RxCUI: 35302 Therapeutic Targets Database: DNC001197 Wikipedia: Sirolimus ZINC: ZINC000169289388
Target Activities (9)
Target Gene Organism Category Pfam pChEMBL Type Source
Q8N122 RPTOR Homo sapiens Human PF02985 PF14538 PF00400 10.2 IC50 ChEMBL
Q9BVC4 MLST8 Homo sapiens Human PF00400 10.2 IC50 ChEMBL
P68106 FKBP1B Homo sapiens Human PF00254 9.7 Kd ChEMBL;BindingDB
P06730 EIF4E Homo sapiens Human PF01652 9.3 Kd ChEMBL;BindingDB
P42345 MTOR Homo sapiens Human PF02259 PF02260 PF08771 PF23593 PF11865 PF00454 9.2 IC50 ChEMBL;BindingDB
P62942 FKBP1A Homo sapiens Human PF00254 9.1 IC50 ChEMBL;BindingDB
Q13451 FKBP5 Homo sapiens Human PF00254 PF00515 PF13181 8.5 Kd ChEMBL;BindingDB
Q02790 FKBP4 Homo sapiens Human PF00254 PF00515 PF07719 8.2 Kd ChEMBL
P14618 PKM Homo sapiens Human PF00224 PF02887 7.3 IC50 ChEMBL;BindingDB
DrugBank Target Actions (12)
Target Gene Target Name Action Type
P02647 P02647 Apolipoproteins binder carriers
P02763 P02763 Alpha-1-acid glycoprotein 1 binder carriers
P02768 ALB Albumin binder carriers
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P20815 CYP3A5 Cytochrome P450 3A5 substrate enzymes
P24462 CYP3A7 Cytochrome P450 3A7 substrate enzymes
P42345 MTOR Serine/threonine-protein kinase mTOR inhibitor targets
Q96FL8 SLC47A1 Multidrug and toxin extrusion protein 1 binder transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 inducer transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
Q9Y6L6 SLCO1B1 Solute carrier organic anion transporter family member 1B1 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters